TME Pharma N.V. Financial Flexibility Index
TME Pharma N.V. financial flexibility index. TME Pharma N.V. (ALTME) has a Financial Flexibility Index of -0.15x as of December 2025. Free cash flow of €-557.00K (operating CF €-557.00K minus capex €0.00) represents 0% of total liabilities (€3.72 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of TME Pharma N.V. (2014–2025)
Financial flexibility index of TME Pharma N.V. from 2014 to 2025. Historical Financial Flexibility Index trend for TME Pharma N.V. across 12 annual periods. Check ALTME cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
TME Pharma N.V. Financial Flexibility Index by Year (2014–2025)
TME Pharma N.V. financial flexibility index by year from 2014 to 2025. Year-by-year free cash flow to debt coverage for TME Pharma N.V.. For the full cash flow conversion analysis, see TME Pharma N.V. (ALTME) cash conversion ratio.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.92x | €-3.42 Million | €-3.42 Million | €3.72 Million | ▲ +64.3% |
| 2024 | -2.58x | €-4.62 Million | €-4.63 Million | €1.79 Million | ▼ -27.8% |
| 2023 | -2.02x | €-5.62 Million | €-5.63 Million | €2.79 Million | ▼ -8.3% |
| 2022 | -1.86x | €-12.12 Million | €-12.14 Million | €6.51 Million | ▲ +20.7% |
| 2021 | -2.35x | €-12.37 Million | €-12.38 Million | €5.27 Million | ▼ -33.9% |
| 2020 | -1.75x | €-5.18 Million | €-5.22 Million | €2.96 Million | ▼ -47.3% |
| 2019 | -1.19x | €-4.27 Million | €-4.29 Million | €3.59 Million | ▼ -112.6% |
| 2018 | -0.56x | €-3.99 Million | €-4.00 Million | €7.12 Million | ▲ +35.9% |
| 2017 | -0.87x | €-4.24 Million | €-4.24 Million | €4.85 Million | ▲ +47.9% |
| 2016 | -1.68x | €-8.97 Million | €-8.99 Million | €5.35 Million | ▼ -62.6% |
| 2015 | -1.03x | €-13.47 Million | €-13.48 Million | €13.07 Million | ▲ +22.5% |
| 2014 | -1.33x | €-12.41 Million | €-12.46 Million | €9.33 Million | — |